You can:
Name | Galanin receptor type 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | GALR1 |
Synonym | GAL1-R GALNR GALNR1 GALR-1 GAL1 receptor |
Disease | Epileptic seizures |
Length | 349 |
Amino acid sequence | MELAVGNLSEGNASWPEPPAPEPGPLFGIGVENFVTLVVFGLIFALGVLGNSLVITVLARSKPGKPRSTTNLFILNLSIADLAYLLFCIPFQATVYALPTWVLGAFICKFIHYFFTVSMLVSIFTLAAMSVDRYVAIVHSRRSSSLRVSRNALLGVGCIWALSIAMASPVAYHQGLFHPRASNQTFCWEQWPDPRHKKAYVVCTFVFGYLLPLLLICFCYAKVLNHLHKKLKNMSKKSEASKKKTAQTVLVVVVVFGISWLPHHIIHLWAEFGVFPLTPASFLFRITAHCLAYSNSSVNPIIYAFLSENFRKAYKQVFKCHIRKDSHLSDTKESKSRIDTPPSTNCTHV |
UniProt | P47211 |
Protein Data Bank | N/A |
GPCR-HGmod model | P47211 |
3D structure model | This predicted structure model is from GPCR-EXP P47211. |
BioLiP | N/A |
Therapeutic Target Database | T78581 |
ChEMBL | CHEMBL4894 |
IUPHAR | 243 |
DrugBank | N/A |
Name | CHEMBL1922021 |
---|---|
Molecular formula | C25H30FN5O2 |
IUPAC name | 6-N-(cyclohexylmethyl)-4-N-(3-fluoro-4-methoxyphenyl)-2-N-(4-methoxyphenyl)pyrimidine-2,4,6-triamine |
Molecular weight | 451.546 |
Hydrogen bond acceptor | 8 |
Hydrogen bond donor | 3 |
XlogP | 6.7 |
Synonyms | BDBM50358669 SCHEMBL10143485 |
Inchi Key | BDISGJJDTGNEDY-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C25H30FN5O2/c1-32-20-11-8-18(9-12-20)29-25-30-23(27-16-17-6-4-3-5-7-17)15-24(31-25)28-19-10-13-22(33-2)21(26)14-19/h8-15,17H,3-7,16H2,1-2H3,(H3,27,28,29,30,31) |
PubChem CID | 57401226 |
ChEMBL | CHEMBL1922021 |
IUPHAR | N/A |
BindingDB | 50358669 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 3840.0 nM | PMID22018787 | BindingDB,ChEMBL |
Inhibition | 60.0 % | PMID22018787 | ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417